GAITHERSBURG, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter 2018 financial and operating results following the close of U.S. financial markets on Wednesday, August 8, 2018.

Conference call details are as follows:

Date: August 8, 2018 Time: 4:30 p.m. U.S. Eastern Time (ET) Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International) Passcode: 5886748 Webcast: www.novavax.com, “Investors”/ “Events” Conference call and webcast replay: Dates: Starting at 7:30 p.m. ET, August 8, 2018 until 7:30 p.m. ET August 15, 2018 Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International) Passcode: 5886748 Webcast: www.novavax.com, “Investors”/ “Events”, until November 8, 2018

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases. It’s RSV and influenza nanoparticle vaccine candidates are Novavax’ most advanced clinical programs and are at the forefront of Novavax’ efforts to improve global health. For more information, please visit www.novavax.com.

Contact:

InvestorsErika TrahanSenior Manager, Investor & Public Relations ir@novavax.com 240-268-2000

Westwicke PartnersJohn Woolford john.woolford@westwicke.com 443-213-0506

MediaSam BrownMike Beyer mikebeyer@sambrown.com 312-961-2502